Cancer Pain

JAMA

Volumn 290, Issue 18, 2003, Pages 2476-2479

  Bruera, Eduardo ^a   Kim, Hak Nam ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; BUPRENORPHINE; BUTORPHANOL; CODEINE; CORTICOSTEROID; DESIPRAMINE; DEXTROPROPOXYPHENE; DONEPEZIL; FENTANYL; GABAPENTIN; HYDROCODONE; HYDROMORPHONE; METHADONE; METHYLPHENIDATE; MORPHINE; NALBUPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE AGONIST; OXYCODONE; PARACETAMOL; PETHIDINE; TRAMADOL;

AGITATION; ALLODYNIA; ANAPHYLAXIS; BRAIN DEPTH STIMULATION; CANCER PAIN; COGNITIVE DEFECT; COMA; CONSTIPATION; CORDOTOMY; DELIRIUM; DISEASE SEVERITY; FATIGUE; GRAND MAL EPILEPSY; HALLUCINATION; HUMAN; HYPERALGESIA; MYOCLONUS; NAUSEA; NEUROTOXICITY; PAIN ASSESSMENT; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SKIN IRRITATION; SWEAT GLAND DISEASE; THALAMOTOMY; TREATMENT INDICATION; URINE RETENTION; WITHDRAWAL SYNDROME;

EID: 0242410340     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.18.2476     Document Type: Review

References (27)

1. World Health Organization. The World Health Report 1996: Fighting Disease, Fostering Development, Executive Summary. Geneva, Switzerland: World Health Organization; 1996.
2. Foley KM. Controlling cancer pain. Hosp Pract (Off Ed). 2000;35:101-108, 111-112.
3. Cherney IN. Cancer pain: principle of assessment and syndromes. In: Berger AM, Portenoy RK, Weissman DE, eds. Principle and Practice of Palliative Care and Supportive Oncology. 2nd ed. Philadelphia, Pa: Lippincott. William & Wilkins; 2002:3-52.
4. Bruera E, Schoeller T, Wenk R, et al. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage. 1995; 10:348-355.
5. Bruera E, Neumann C. History and clinical examination of the cancer pain patient: assessment and measurement. In: Rice A, Warfield C, Justin D, Eccleston C, eds. Clinical Pain Management Cancer Pain. New York, NY: Oxford University Press; 2003:63-71.
6. Bruera E, Neumann CM. Respective limits of palliative care and oncology in the supportive care of cancer patients. Support Care Cancer. 1999;7:321-327.
7. Guidelines for using the Edmonton Symptom Assessment System (ESAS). Available at: http:// www.palliative.org/PC/ClinicalInfo/Assessment Tools?easa.pdf. Accessibility verified October 24, 2003.
8. Zech DFJ, Grond S, Lynch J, et al. Validation of the World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63:65-76.
9. Rawlins MD. Non-opioid analgesics. In: Doyle D, Hanks GW, MacDonald N, eds. Palliative Medicine. 2nd ed. New York, NY: Oxford University Press; 1998: 355-361.
10. Ripamonti C. Pharmacology of opioid analgesia: clinical principles. In: Bruera E, Portenoy RK, eds. Cancer Pain. Cambridge, England: Cambridge University Press; 2003:124-149.
11. Ripamonti C, Zecca E, De Conno F. Pharmacological treatment of cancer pain: alternative routes of opioid administration. Tumori. 1998;84:289-300.
12. Bruera E, Macmillan K, Hanson J, MacDonald RN. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain. 1989; 39:13-16.
13. Bruera E, Brenneis C, Paterson AHG, MacDonald RN. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage. 1989;4:3-6.
14. Bruera E, Driver L, Barnes EA, et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol. In press.
15. Bruera E, Strasser F, Shen L, et al. The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study. J Pain Symptom Manage. In press.
16. Centeno C, Gonzalez C. Radiotherapy for palliative of symptoms. In: Fisch H, Bruera E. Handbook of Advanced Cancer Care. Cambridge, England: Cambridge University Press; 2003:27-39.
17. Pereira J. Management of bone pain. In: Portenoy R, Bruera E, eds. Topics in Palliative Care. Vol 3. New York, NY: Oxford University Press; 1998:79.
18. Ross JR, Saunders Y, Edmonds PM, et al. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ. 2003;327:469-472.
19. Coluzzi PH, Schwartzberg L, Conroy JD, et al. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain. 2001; 91:123-130.
20. Bruera E, Seifert L, Watanabe S, et al. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage. 1996;11:147-153.
21. Mancini I, Bruera E. Constipation. In: Ripamonti C, Bruera E, eds. Gastrointestinal Symptoms in Advanced Cancer Patient. New York, NY: Oxford University Press; 2002:193-206.
22. Strasser F, Bruera E. Side effects of opioid analgesia. In: Bruera E, Portenoy RK, eds. Cancer Pain. Cambridge, England: Cambridge University Press; 2003. In press.
23. Bruera E, Pereira J, Watanabe S, et al. Opioid rotation in patients with cancer pain: a retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer. 1996;78:852-857.
24. Bruera E, Sweeney C. Methadone use in cancer patients with pain: a review. J Palliat Med. 2002;5: 127-138.
25. Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain, part 3: clinical strategies to improve opioid responsiveness. J Pain Symptom Manage. 2001;21:338-354.
26. Hassenbusch SJ, Johns L. Neurosurgical techniques in the management of cancer pain. In: Bruera E, Portenoy R, eds. Cancer Pain. Cambridge, England: Cambridge University Press; 2003:261-276.
27. Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040-4049.